Huabio
Huabio is a privately held life sciences company that develops and distributes a catalog of more than 17,000 antibody reagents and related proteins for academic, pharmaceutical, and biotechnology researchers worldwide, operating from Hangzhou, China and Woburn, Massachusetts.
- Company typePrivate
- Founded2007
- HeadquartersNew Boston, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Huabio does
Huabio is a privately held life sciences company that develops, manufactures, and distributes antibody reagents and related protein products for research and diagnostic applications. Founded in 2007, the company operates a catalog of more than 17,000 antibodies spanning over 10,000 targets, built around its proprietary rabbit single B cell antibody development platform and a high-throughput recombinant protein production workflow. The portfolio includes recombinant rabbit monoclonal antibodies, mouse monoclonals, rabbit polyclonals, alpaca nanobodies, secondary antibodies, ELISA kits, recombinant proteins, magnetic beads, and the proprietary MESA-IRS® multiplex immunofluorescence (mIHC) spatial antibody line, all backed by ISO9001 and ISO13485 quality system certifications and rigorous batch-to-batch consistency testing. Custom monoclonal and polyclonal antibody development services complement the catalog with quote-based project work.
The company runs a hybrid go-to-market: a Shopify-powered direct e-commerce storefront serves researchers and smaller accounts globally, while a network of authorized distributors handles localized sales, technical support, and fulfillment across international markets. Catalog antibodies are sold at unit pricing (approximately $385 per 100μl) on a pay-as-you-go basis, and custom services are contracted on a project basis. The primary operational headquarters is in Hangzhou, Zhejiang, with a commercial and customer-support office in Woburn, Massachusetts, enabling direct US sales and bilingual support. Customers span academic and institutional life science researchers across cancer, immunology, neuroscience, cell biology, epigenetics, cardiovascular, metabolism, developmental biology, microbiology, and stem cell research, as well as pharmaceutical and biotechnology buyers working on biomarker discovery, diagnostic assay development, and therapeutic antibody research.
Huabio's revenue mechanics are anchored in high-volume, small-ticket catalog transactions rather than large enterprise contracts, with no disclosed enterprise customers, named logos, or institutional investors appearing in the available data. Strategic emphasis is on catalog breadth, batch-to-batch reproducibility, and quality system certifications as differentiators against lower-cost catalog competitors, with newer pushes into spatial biology (mIHC) and ADC-related reagents suggesting modest adjacency expansion rather than a fundamental pivot.
Huabio firmographics
Firmographics- Name
- Huabio
- Legal name
- HUABIO
- Website
- https://huabio.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Huabio is a privately held life sciences company that develops and distributes a catalog of more than 17,000 antibody reagents and related proteins for academic, pharmaceutical, and biotechnology researchers worldwide, operating from Hangzhou, China and Woburn, Massachusetts.
- Ownership category
- akta.pro rank
Where Huabio is headquartered
LocationHeadquarters
- HQ city
- New Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Huabio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Catalog Antibody and Protein Products: Sale of catalog products including recombinant rabbit monoclonal antibodies, mouse monoclonal antibodies, rabbit polyclonal antibodies, alpaca antibodies, fluorescent direct-labeled antibodies, secondary antibodies, cytokines/proteins, and ELISA kits. Individual product purchases at unit pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard catalog antibodies - $385 per 100μl |
| Other | Multi-year contract | Custom antibody development services - quote-based pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Huabio product offering
Product offeringCore offering
Huabio develops, manufactures, and sells a catalog of more than 17,000 antibody products covering over 10,000 protein targets, using its proprietary rabbit single B cell recombinant antibody platform. The portfolio includes recombinant rabbit monoclonal antibodies, mouse monoclonal antibodies, rabbit polyclonal antibodies, alpaca nanobodies, secondary antibodies, ELISA kits, recombinant proteins, magnetic beads, flow cytometry antibodies, and MESA-IRS® spatial antibodies for multiplex immunofluorescence. The company also offers custom monoclonal and polyclonal antibody development services on a quote basis, supported by ISO9001 and ISO13485 certified quality systems.
Product overview
Huabio is a life sciences company specializing in high-quality antibody products and custom antibody development services. The company's portfolio includes a comprehensive catalog of over 17,000 primary antibodies covering more than 10,000 targets, encompassing recombinant rabbit monoclonal antibodies (developed using proprietary rabbit single B cell technology), mouse monoclonal antibodies, rabbit polyclonal antibodies, alpaca nanobodies, and secondary antibodies. The product line extends to specialized offerings including MESA-IRS spatial antibodies for multiplex immunofluorescence (mIHC), ELISA kits with pg-level sensitivity, recombinant proteins for organoid research, matched antibody pairs, magnetic beads, and flow cytometry-validated antibodies. Huabio also provides custom antibody development services for both monoclonal (mouse and rabbit) and polyclonal antibody production. The company serves research areas including cancer, immunology, cell biology, neuroscience, metabolism, epigenetics, cardiovascular, developmental biology, and stem cells. Quality is maintained through ISO9001 and ISO13485 certifications.
Differentiator
Problem solved
Functional benefit
Products and services
- Recombinant Rabbit Monoclonal Antibodies Recombinant monoclonal antibodies developed using Huabio's proprietary rabbit single B cell antibody technology, offering high specificity and reproducibility for life science research applications.
- Mouse Monoclonal Antibodies Traditional hybridoma-derived monoclonal antibodies for research applications including Western Blot, IHC, IF, and Flow Cytometry.
- Rabbit Polyclonal Antibodies Validated polyclonal antibodies produced in rabbits, offering broad epitope recognition for various research applications.
- Alpaca Nanobodies Single-domain antibodies derived from alpacas, offering small size and high specificity for challenging research applications.
- Secondary Antibodies HRP and fluorescently labeled secondary antibodies including Goat anti-Rabbit IgG-HRP and iFluor conjugated antibodies for detection systems in immunoassays.
- MESA-IRS® Spatial Antibodies (mIHC) Proprietary multiplex immunofluorescence (mIHC) antibodies including popular panels and TSA staining kits for spatial biology research.
- ELISA Kits Enzyme-Linked Immunosorbent Assay kits with sensitivity at picogram level and wide detection range, validated with native samples.
- Recombinant Proteins High-quality recombinant proteins including cytokines and growth factors for organoid research and other applications.
- Antibody Pairs Matched antibody pairs for sandwich ELISA and other diagnostic assay development applications.
- Magnetic Beads Magnetic beads for immunoprecipitation and other antibody-based separation applications.
- Flow Cytometry Antibodies Antibodies optimized and validated specifically for flow cytometry applications.
- Custom Monoclonal Antibody Services Custom antibody development services including mouse and rabbit monoclonal antibody production using hybridoma technology, priced via quote request.
- Custom Polyclonal Antibody Services Custom rabbit polyclonal antibody development and production services, priced via quote request.
- ADC Drug Small Molecule Detection Antibodies Antibody-drug conjugate (ADC) related products including small molecule detection antibodies for pharmaceutical research.
- Fluorescent Direct-Labeled Antibodies Antibodies pre-conjugated with fluorescent dyes for direct detection in immunofluorescence applications.
Companies that use Huabio
Customer profileSegments2 records
Ideal customer profiles2 records
Huabio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Huabio partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights6 records
Huabio competitors and assessment
Company assessmentDirect peers
- Cell Signaling Technology: US-based leading supplier of high-quality antibodies with a strong recombinant rabbit monoclonal antibody portfolio and broad catalog across signaling and disease research—directly comparable in target customer (academic/biopharma researchers) and product mix.
- Abcam: Global antibody reagent supplier (now part of Danaher) with the broadest research antibody catalog; competes head-to-head with Huabio in catalog breadth, recombinant monoclonals, and custom services for academic and pharma researchers.
- Novus Biologicals (Bio-Techne): Research antibody and reagent catalog under Bio-Techne, with comparable breadth in primary antibodies, ELISA kits, and recombinant proteins; directly overlaps Huabio's product mix and target customers.
- Atlas Antibodies: Specialist supplier of validated research antibodies (notably the Human Protein Atlas portfolio) with a focused catalog and emphasis on target specificity—comparable mid-scale antibody specialist competing for academic and pharma buyers.
- GeneTex: Research antibody supplier with comparable catalog scale and a focus on recombinant antibodies and validation; similar profile as a mid-sized antibody specialist competing for academic and biotech researchers.
- Santa Cruz Biotechnology: Long-established catalog antibody supplier serving academic and pharma research with primary antibodies, secondary antibodies, and supporting reagents—competes on catalog breadth and price with Huabio.
- Proteintech Group: Privately held antibody manufacturer with a comparable catalog-plus-custom-service model and emphasis on recombinant rabbit monoclonals; similar mid-scale positioning to Huabio with strong reputation among academic researchers.
Broad incumbents
- BD Biosciences: Major life sciences tools provider offering flow cytometry antibodies and supporting reagents; competes with Huabio in flow cytometry and immunology reagent categories within a much broader product portfolio.
- Bio-Techne: Large life sciences tools platform encompassing R&D Systems, Novus Biologicals, and ProteinSimple—competes with Huabio across antibodies, proteins, and ELISA kits as a broader incumbent rather than a focused antibody specialist.
- Thermo Fisher Scientific: Operates the Invitrogen antibody business alongside a vast life sciences portfolio; competes with Huabio in primary and secondary antibodies, ELISA kits, and flow cytometry reagents as part of a much wider product offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Huabio social profiles
Digital presenceHuabio compliance and trust
Trust signalCompliance2 records
Huabio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Huabio leadership team
Management profileNumber of profiles
Huabio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Huabio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Huabio
What does Huabio do?
Huabio develops, manufactures, and sells a catalog of more than 17,000 antibody products covering over 10,000 protein targets, using its proprietary rabbit single B cell recombinant antibody platform. The portfolio includes recombinant rabbit monoclonal antibodies, mouse monoclonal antibodies, rabbit polyclonal antibodies, alpaca nanobodies, secondary antibodies, ELISA kits, recombinant proteins, magnetic beads, flow cytometry antibodies, and MESA-IRS® spatial antibodies for multiplex immunofluorescence. The company also offers custom monoclonal and polyclonal antibody development services on a quote basis, supported by ISO9001 and ISO13485 certified quality systems.
Is Huabio a public or private company?
Huabio is a private company. It is classified as unknown and is currently operating.
When was Huabio founded?
Huabio was founded in 2007. It employs 101 to 250 people.
Where is Huabio based?
Huabio is headquartered in New Boston, United States, in the North America region.
How does Huabio make money?
One revenue line is on record: catalog Antibody and Protein Products.
Who are Huabio's main competitors?
Direct peers on record are Cell Signaling Technology, Abcam, Novus Biologicals (Bio-Techne), Atlas Antibodies, GeneTex, Santa Cruz Biotechnology and Proteintech Group. Broad incumbents are BD Biosciences, Bio-Techne and Thermo Fisher Scientific.
Does Huabio have an API?
No public API is recorded for Huabio.